Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Steven A. Curley

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9533-2769; OpenAlex author ID A5042809748. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 2 papers

Papers 11

  1. Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatment. Last author DOI 10.1038/s41598-019-57155-7↗
  2. Magnetic resonance imaging in the assessment of pancreatic cancer with quantitative parameter extraction by means of dynamic contrast-enhanced magnetic resonan… Co-author DOI 10.1177/1756284819885052↗
  3. Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts. Co-author DOI 10.1016/j.tranon.2018.02.023↗
  4. Development of photoactive Sweet-C60 for pancreatic cancer stellate cell therapy. Co-author DOI 10.2217/nnm-2018-0239↗
  5. Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach. Co-author DOI 10.1038/s41598-017-03040-0↗
  6. Generation of an in vitro 3D PDAC stroma rich spheroid model. Last author DOI 10.1016/j.biomaterials.2016.08.041↗
  7. Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell Spheroids Using an Improved Hanging Drop Technique. Co-author DOI 10.1089/ten.tec.2015.0280↗
  8. Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells. Co-author DOI 10.1002/cncr.28895↗
  9. Association of diabetes and perineural invasion in pancreatic cancer. Co-author DOI 10.1002/cam4.43↗
  10. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG. Last author DOI 10.1016/j.jss.2011.09.017↗
  11. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.1371/journal.pone.0020347↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew J. Ware · 5 shared papers, 2016–2018 · strength 0.34
  2. Stuart J. Corr · 5 shared papers, 2016–2018 · strength 0.34
  3. Maciej Serda · 2 shared papers, 2018–2020 · strength 0.21
  4. Biana Godin · 3 shared papers, 2016–2017 · strength 0.19
  5. Martyna Krzykawska-Serda · 2 shared papers, 2018 · strength 0.16
  6. Katarzyna Malarz · 1 shared paper, 2020 · strength 0.13
  7. Antonio Avallone · 1 shared paper, 2020 · strength 0.10
  8. Raffaéle Palaia · 1 shared paper, 2020 · strength 0.10
  9. Vincenza Granata · 1 shared paper, 2020 · strength 0.10
  10. Antonella Petrillo · 1 shared paper, 2020 · strength 0.10
  11. Francesco Izzo · 1 shared paper, 2020 · strength 0.10
  12. Hermann B. Frieboes · 1 shared paper, 2017 · strength 0.07
  13. Nadezhda V. Koshkina · 1 shared paper, 2014 · strength 0.06
  14. Rosa F. Hwang · 1 shared paper, 2016 · strength 0.05
  15. David James McConkey · 1 shared paper, 2012 · strength 0.04
  16. Heping Liu · 1 shared paper, 2012 · strength 0.04
  17. James L. Abbruzzese · 1 shared paper, 2012 · strength 0.03
  18. Motofumi Tanaka · 1 shared paper, 2012 · strength 0.03
  19. Manal M. Hassan · 1 shared paper, 2012 · strength 0.03
  20. İbrahim Halil Şahin · 1 shared paper, 2012 · strength 0.03
  21. Donghui Li · 1 shared paper, 2012 · strength 0.03
  22. Resham Bhattacharya · 1 shared paper, 2011 · strength 0.02
  23. Vijay H. Shah · 1 shared paper, 2011 · strength 0.02
  24. Jameel Ahmad Khan · 1 shared paper, 2011 · strength 0.02
  25. Rachel A. Kudgus · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.